SEC Form DFiling only, no announcement found
Cardiosense, based in Chicago, IL, reported $26,137,050 sold in a private offering of equity and options or warrants and Convertible Promissory Notes have converted into equity in connection with this transaction, with the first sale on August 7, 2026, in a Form D filed with the SEC on August 24, 2026. The filing says 30 investors have already invested. The offering authorizes up to $42,012,230.
Legal name on the filing: Cardiosense, Inc..
| Amount sold | $26,137,050Basis: Form D total amount sold, as of the filing of August 24, 2026. Not the announced round size. |
|---|---|
| Total offering | $42,012,230The most the company may sell under this offering. Not money raised. |
| Remaining to be sold | $15,875,180 |
| Securities offered | Equity; Security to be acquired upon exercise of option, warrant or other right; Other (Convertible Promissory Notes have converted into equity in connection with this transaction) |
| Exemption claimed | Rule 506(b) |
| Date of first sale | August 7, 2026 |
| Investors already invested | 30 |
| Non-accredited investors | None |
| Minimum investment accepted | $0 |
| Part of a merger or acquisition | No |
| Industry group | Other Health Care |
| Principal place of business | Chicago, IL |
| Jurisdiction of incorporation | DELAWARE |
| Entity type | Corporation |
| Year of incorporation | over five years ago |
| Revenue range | Decline to Disclose |
| SEC CIK | 1957335 |
Round name, valuation, lead investor and participants are not on a Form D, so they are not shown. They appear here only when a press or company announcement is matched to this deal.
| Name, as filed | Relationship | VC Beast profile |
|---|---|---|
| Eric Meizlish | Executive Officer, Director | None linked |
| Andrew Michael Carek | Executive Officer | None linked |
| Daniel Gottlieb | Director | None linked |
| Bimal Shah | Director | None linked |
| Jeffrey Trost | Director | None linked |
| Lauren Pierce Flickinger | Director | None linked |
| Omer Tolga Inan | Executive Officer, Director | None linked |
Form D lists the company's executive officers, directors and promoters. A director is often an investor's board representative, but the filing does not say who invested.
| Filed | Form | Amount sold | Total offering |
|---|---|---|---|
| Aug 24, 2026 | D (original) | $26,137,050 | $42,012,230 |
The latest filing states the current amount sold; an amendment replaces the figure before it.
From the issuer's EDGAR filing history. Amounts are shown for filings in our warehouse, which holds operating-company filings from July 16, 2026.
Filing only, no announcement found. The only source for this deal is the company's own SEC filing, made under penalty of law. When a press or company announcement is matched to it, it is cited here with the round name it gives.
Amount sold is the filing's total amount sold; total offering is its authorized maximum. This page was built from filings received through September 29, 2026. Report an error on the corrections page.
Cite this deal
VC Beast, "Cardiosense: SEC Form D deal record", https://vcbeast.com/deals/cardiosense-form-d-2026-08-07. Source: SEC EDGAR, accession 0001957335-26-000003.